Beth C Seidenberg's Net Worth

Beth C Seidenberg's net worth is estimated to be at least $7,150,386.63 as of 11/08/2024. CoreStreet's estimation of Beth C Seidenberg's net worth is based on their sale of stock and current holding of stock.

Beth C Seidenberg is Director at Vera Therapeutics Inc. They have executed at least 19 trades of stock as per SEC Form 4 filings. Their most recent trade was for 15,000 units of VERA stock on 10/28/2024. Their biggest sale was on 12/14/2020 when they sold 38,461 units of Progyny Inc stock for $1,615,362.00. They typically trade 6 times per year.

Total value of insider buys:
  • $3,495,882.86
Total value of insider sells:
  • $3,654,503.77
Most recent insider trade:
  • Oct. 28, 2024

Beth C Seidenberg's Insider Trading History

Vera Therapeutics IncTitleAmountPriceTypeTotal Value
Oct. 28, 2024
Director15,000$48.03Sell$720,450.00
Sept. 18, 2024
Director1,177$42.01Sell$49,445.77
March 30, 2023
Director2,300$7.24Buy$16,652.00
March 27, 2023
Director1,633$7.24Buy$11,822.92
March 24, 2023
Director1,833$7.24Buy$13,270.92
March 20, 2023
Director15,252$7.21Buy$109,966.92
March 17, 2023
Director74,045$7.12Buy$527,200.40
March 15, 2023
Director32,844$7.12Buy$233,849.28
March 10, 2023
Director48,003$7.16Buy$343,701.48
March 3, 2023
Director1,000$7.25Buy$7,250.00
March 1, 2023
Director100$7.25Buy$725.00
Feb. 23, 2023
Director200$7.24Buy$1,448.00
Feb. 13, 2023
Director10,072$7.20Buy$72,518.40
Feb. 8, 2023
Director45,357$7.22Buy$327,477.54
Sagimet Biosciences Inc. Series A Common StockTitleAmountPriceTypeTotal Value
July 18, 2023
Director46,875$16.00Buy$750,000.00
ACELYRIN, INC. Common StockTitleAmountPriceTypeTotal Value
May 9, 2023
Director60,000$18.00Buy$1,080,000.00
Progyny IncTitleAmountPriceTypeTotal Value
Dec. 14, 2020
Director38,461$42.00Sell$1,615,362.00
Nov. 27, 2020
Director19,231$36.00Sell$692,316.00
Aug. 11, 2020
Director19,231$30.00Sell$576,930.00